Sath Shukla - CEO & President at Spero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO & President
Issuer Symbol
SPRO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sath Shukla since 09 Mar 2025

Holdings reported by Sath Shukla for Spero Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,736,883 $1,354,769 $0.7800 05 Feb 2025 Direct

Transactions reported by Sath Shukla for Spero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.